Investors

The major activity carried out by FIT Biotech has been the development of an HIV vaccine.


This project has been supported by Finish institutional investors, Finish National Fund for Development and Innovation as well as by several grants from the European Commission.

Developing life-changing vaccines

 

FIT Biotech´s biotechnical innovations in the field of developing life-changing vaccines are also financiered by several funds, foundations and individual shareholders who share the interest of developing vaccines in order to cherish and improve human dignity. To learn more about our values and investors, please see page FIT Biotech.

If you wish to be a part of FIT Biotech´s vaccine research and development against life threatening diseases, please contact us.